Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Chugai Pharmaceutical Co., Ltd. CHGCY

Full chart Compare
Set alert

Price alert · CHGCY

All alert types
22.12 USD +0.60 (+2.79%)

At closeNov 4, 2026, 4:00 PM EST

21.89 Day range 22.15
18.33 52-week range 34.84
YTD
-15.80%
1 year
-1.47%

Financial health

Altman Z-Score

26.83 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

7 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

A4 / 5 overall

  • DCF 3
  • Return on Equity 5
  • Return on Assets 5
  • Debt / Equity 4
  • P/E 3
  • P/B 2

Valuation

P/E 29.8×
FY 2016: 35.3×FY 2017: 43.3×FY 2018: 37.7×FY 2019: 35.0×FY 2020: 42.0×FY 2021: 20.4×FY 2022: 14.6×FY 2023: 26.9×FY 2024: 29.4×FY 2025: 29.8×
FY 2016 5y median 26.9× FY 2025
P/S 10.3×
FY 2016: 3.9×FY 2017: 5.9×FY 2018: 6.0×FY 2019: 8.0×FY 2020: 11.5×FY 2021: 6.2×FY 2022: 4.3×FY 2023: 7.9×FY 2024: 9.7×FY 2025: 10.3×
FY 2016 5y median 7.9× FY 2025
P/B 6.7×
FY 2016: 2.9×FY 2017: 4.5×FY 2018: 4.6×FY 2019: 6.5×FY 2020: 9.2×FY 2021: 5.2×FY 2022: 3.8×FY 2023: 5.4×FY 2024: 6.0×FY 2025: 6.7×
FY 2016 5y median 5.4× FY 2025
P/FCF 41.3×
FY 2016: 801×FY 2017: 49.9×FY 2018: 84.1×FY 2019: 37.9×FY 2020: 62.9×FY 2021: 29.9×FY 2022: 31.6×FY 2023: 26.0×FY 2024: 29.0×FY 2025: 41.3×
FY 2016 5y median 29.9× FY 2025
EV/EBITDA 19.9×
FY 2016: 19.3×FY 2017: 26.1×FY 2018: 27.4×FY 2019: 22.7×FY 2020: 26.8×FY 2021: 13.2×FY 2022: 9.3×FY 2023: 17.4×FY 2024: 18.8×FY 2025: 19.9×
FY 2016 5y median 17.4× FY 2025
EV/Sales 10.0×
FY 2016: 3.7×FY 2017: 5.6×FY 2018: 5.8×FY 2019: 7.8×FY 2020: 11.2×FY 2021: 5.9×FY 2022: 4.2×FY 2023: 7.5×FY 2024: 9.3×FY 2025: 10.0×
FY 2016 5y median 7.5× FY 2025
FCF Yield 2.4%
FY 2016: 0.1%FY 2017: 2.0%FY 2018: 1.2%FY 2019: 2.6%FY 2020: 1.6%FY 2021: 3.3%FY 2022: 3.2%FY 2023: 3.8%FY 2024: 3.5%FY 2025: 2.4%
FY 2016 5y median 3.3% FY 2025

Profitability

Gross Margin 71.1%
FY 2016: 49.6%FY 2017: 52.4%FY 2018: 54.7%FY 2019: 61.2%FY 2020: 65.2%FY 2021: 66.2%FY 2022: 62.2%FY 2023: 62.8%FY 2024: 71.0%FY 2025: 71.1%
FY 2016 5y median 66.2% FY 2025
Operating Margin 46.9%
FY 2016: 15.6%FY 2017: 18.5%FY 2018: 21.4%FY 2019: 30.7%FY 2020: 38.3%FY 2021: 42.2%FY 2022: 42.3%FY 2023: 39.5%FY 2024: 46.3%FY 2025: 46.9%
FY 2016 5y median 42.3% FY 2025
Net Margin 34.5%
FY 2016: 10.9%FY 2017: 13.6%FY 2018: 16.0%FY 2019: 23.0%FY 2020: 27.3%FY 2021: 30.3%FY 2022: 29.7%FY 2023: 29.3%FY 2024: 33.1%FY 2025: 34.5%
FY 2016 5y median 30.3% FY 2025
ROE 22.4%
FY 2016: 8.3%FY 2017: 10.5%FY 2018: 12.2%FY 2019: 18.4%FY 2020: 21.9%FY 2021: 25.5%FY 2022: 26.3%FY 2023: 20.0%FY 2024: 20.4%FY 2025: 22.4%
FY 2016 5y median 22.4% FY 2025
ROIC 21.7%
FY 2016: 8.4%FY 2017: 10.5%FY 2018: 12.1%FY 2019: 18.0%FY 2020: 21.7%FY 2021: 25.0%FY 2022: 25.9%FY 2023: 19.5%FY 2024: 20.1%FY 2025: 21.7%
FY 2016 5y median 21.7% FY 2025
ROA 18.4%
FY 2016: 6.6%FY 2017: 8.5%FY 2018: 10.1%FY 2019: 14.9%FY 2020: 17.4%FY 2021: 19.7%FY 2022: 20.0%FY 2023: 16.8%FY 2024: 17.5%FY 2025: 18.4%
FY 2016 5y median 18.4% FY 2025

Growth (YoY)

Revenue 12.7%
FY 2016: -1.4%FY 2017: 8.6%FY 2018: 8.5%FY 2019: 18.4%FY 2020: 14.7%FY 2021: 27.0%FY 2022: 26.0%FY 2023: -11.8%FY 2024: 5.3%FY 2025: 12.7%
FY 2016 FY 2025
Operating Income 14.2%
FY 2016: -11.4%FY 2017: 28.7%FY 2018: 25.7%FY 2019: 69.4%FY 2020: 43.0%FY 2021: 40.1%FY 2022: 26.4%FY 2023: -17.7%FY 2024: 23.4%FY 2025: 14.2%
FY 2016 FY 2025
EPS (diluted) 17.5%
FY 2016: -12.3%FY 2017: 35.6%FY 2018: 27.0%FY 2019: 70.4%FY 2020: 36.2%FY 2021: 41.1%FY 2022: 23.6%FY 2023: -13.1%FY 2024: 19.0%FY 2025: 17.5%
FY 2016 FY 2025
Free Cash Flow -16.4%
FY 2016: -93.7%FY 2017: 2567.9%FY 2018: -34.4%FY 2019: 251.3%FY 2020: -1.3%FY 2021: 44.0%FY 2022: -16.4%FY 2023: 94.2%FY 2024: 17.0%FY 2025: -16.4%
FY 2016 FY 2025

Financial Health

Current Ratio 4.2×
FY 2016: 4.7×FY 2017: 4.9×FY 2018: 4.4×FY 2019: 3.9×FY 2020: 3.5×FY 2021: 3.2×FY 2022: 3.2×FY 2023: 4.7×FY 2024: 5.5×FY 2025: 4.2×
FY 2016 5y median 4.2× FY 2025
Quick Ratio 3.6×
FY 2016: 3.2×FY 2017: 3.5×FY 2018: 3.3×FY 2019: 3.0×FY 2020: 2.8×FY 2021: 2.6×FY 2022: 2.5×FY 2023: 3.8×FY 2024: 4.7×FY 2025: 3.6×
FY 2016 5y median 3.6× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA -0.6×
FY 2016: -1.0×FY 2017: -1.2×FY 2018: -1.2×FY 2019: -0.8×FY 2020: -0.6×FY 2021: -0.6×FY 2022: -0.4×FY 2023: -0.9×FY 2024: -0.9×FY 2025: -0.6×
FY 2016 5y median -0.6× FY 2025
Interest Coverage 575×
FY 2016: 894×FY 2017: 899×FY 2018: 1120×FY 2019: 1685×FY 2020: 4859×FY 2021: 8790×FY 2022: 8743×FY 2023: 16266×FY 2024: -528×FY 2025: 575×
FY 2016 5y median 8743× FY 2025

Dividends

Dividend Yield 2.3%
FY 2016: 1.7%FY 2017: 1.0%FY 2018: 1.0%FY 2019: 1.0%FY 2020: 1.0%FY 2021: 1.6%FY 2022: 2.5%FY 2023: 1.5%FY 2024: 1.2%FY 2025: 2.3%
FY 2016 5y median 1.6% FY 2025
Payout Ratio 69.0%
FY 2016: 59.1%FY 2017: 41.3%FY 2018: 37.9%FY 2019: 35.8%FY 2020: 42.6%FY 2021: 32.6%FY 2022: 36.9%FY 2023: 40.4%FY 2024: 34.4%FY 2025: 69.0%
FY 2016 5y median 36.9% FY 2025

Annual · latest fiscal year ends 2025-12-31